(RTTNews) - Arcutis Biotherapeutics Inc.'s (ARQT) ZORYVE cream 0.15% provided consistent and meaningful improvements in signs and symptoms of atopic dermatitis in individuals regardless of race, ...

Please provide your email address to receive an email when new articles are posted on . The photopneumatic device improved acne in 66.7% of patients in this 7-week trial. Improvements were seen across ...

In a cohort study, fractional CO2 laser therapy was effective in treating postburn hypertrophic scars, with significant improvements in scar vascularity, pigmentation, and pliability across ...